SEC FORM 4
—
ZEVRA THERAPEUTICS, INC. (ZVRA)
Acquisition (code M) of 50,000 shares; price not stated (see filing).
Reporting Person McFarlane Neil F. · Officer Title President and CEO · Transaction Code M
Traded Oct 10, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001434647-26-000075 · filed 2026-10-13 · View filing →